U.S. researchers claim to have identified a groundbreaking drug that could restore heart muscle function following a heart attack. A new study describes how MSI-1436, a naturally occurring compound, regenerates heart muscle tissue in zebrafish and mice. The animals are separated by 450 million years of evolution, raising hopes that the drug could help heal human hearts to…
Some animals have the ability to regenerate lost limbs. For humans, regeneration has been limited to the liver and skin. Researchers at the Mount Desert Island Biological Laboratory say the ability to re-grow other human tissue – like the heart – may be more possible than you think especially with their latest discovery.
ABC7/Fox 22 interviews MDI Biological Laboratory scientist Voot P. Yin, Ph.D., about MSI-1436, a drug candidate that has been shown to stimulate the regeneration of heart muscle tissue in zebrafish and mice. The goal of scientists at the MDI Biological Laboratory is to move the drug into clinical trails in humans as a potential treatment for the regeneration of heart muscle tissue following a heart attack.
Researchers at Mount Desert Island Biological Laboratory in Bar Harbor may have discovered how a drug derived from a molecule found in dogfish sharks could someday help people recover from heart attacks and heart disease.
WLBZ2 TV interviews MDI Biological Laboratory scientist Voot P. Yin, Ph.D., on his research on MSI-1436, a drug candidate that could potentially be used to restore heart muscle tissue following a heart attack.
At the MDI Biological Laboratory, scientists study lower organisms that have retained the miraculous ability to regenerate organs and tissues. Dr. Voot Yin talks about how research on the common aquarium fish, the zebrafish, may lead to a drug to regenerate healthy heart tissue after a heart attack.
A new heart disease treatment successfully induced and accelerated regeneration of damaged tissue in zebrafish and mice. The U.S. Patent and Trademark Office is awarding a patent for the drug and further trials into its efficacy are planned.
A patent award for a new drug could save the lives of many who are suffering from heart disease.
The US Patent and Trademark Office recently announced they will grant a patent to MDI Biological Laboratory. The patent will allow the lab to use a molecule named MSI-1436, which could be used to stimulate the regeneration and repair of heart tissue.
Though it sounds like science fiction, limb regeneration in humans is entirely within the realm of possibility. It can also help in wound healing and in the development of highly sophisticated prosthetic devices that are much more sensitive and effective than those currently in use.